investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Immune Suppressor Mechanism in a Murine Model of Hepatitis and Liver Cancer
Tim Greten
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Manns
Hannover Medical School
Hanover, Germany
Tim Greten
National Cancer Institute (NIH)
Rockville, United States
Related projects
John Tavis
N-hydroxyisoquinolinediones as HCC Preventatives
Liver and intrahepatic bile ducts
Pathology
Xin Wei Wang
Molecular Signatures for Liver Cancer Diagnosis and Treatment Stratification
Liver and intrahepatic bile ducts
Pathology
Frank Gonzalez
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers – Rockville
Liver and intrahepatic bile ducts
Pathology
Tim Greten
Immune Suppressor Mechanism Analysis in Patients with Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
John Tavis
Alpha Hydroxytropolones as HCC Preventatives
Liver and intrahepatic bile ducts
Pathology
Ju-Seog Lee
Validation of Prognostic Markers in Advanced Hepatocellular Carcinoma and Identification of Potention Serological Prognostic Markers
Liver and intrahepatic bile ducts
Pathology
Geoffrey D Girnun
Metabolic control of hepatocellular carcinoma by PGC1alpha
Liver and intrahepatic bile ducts
Pathology
Xin Chen
Molecular Genetics of Liver Cancers
Liver and intrahepatic bile ducts
Pathology
Lewis R Roberts
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
